American Journal of Transplantation

Article	Citations
Dual Kidney Transplantation from Extended Marginal Donors in the United States: An analysis of SRTR and Literature Review	332
Benefits Of Preemptive Transplantation In Older Patients with High KDPI Kidneys: Is Sooner Better Than Later?	318
Are we closer to abandoning protocol graft biopsies after pediatric liver transplantation?	290
Optimization of donor flow matching and portal modulation to decrease small for size syndrome in Living Donor Liver Transplant - A Single Center American Experience	219
Deceased Kidney Donors on Dialysis Create Opportunities for Renal Transplantation: A Single Center Experience	214
Outcomes By Epstein-Barr Virus Serostatus In Pediatric Kidney Transplantation	148
Organ Procurement and Transplantation Network Infrastructure: A High-Value Investment for the Government	147
Rejection and graft vasculopathy secondary to effects of Crohn's disease in a heart-transplanted child	140
Advancements in imaging modalities for post-kidney transplant monitoring: A focus on contrast-enhanced ultrasound	138
Phage-display immunoprecipitation for precision mapping the autoreactome	133
Atezolizumab plus bevacizumab as a downstaging therapy for liver transplantation in hepatocellular carcinoma with portal vein thrombosis: The first report	132
OPTN/SRTR 2021 Annual Data Report: Lung	130
Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation	122
Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020	118
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients	116
Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave	114
SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19	109
Validation of a novel donor lung scoring system based on the updated lung Composite Allocation Score	105
Comparative outcomes for over 100 deceased donor kidney transplants from SARS-CoV-2 positive donors: A single-center experience	103
OPTN/SRTR 2021 Annual Data Report: COVID-19	98
Enhancing National Liver Review Board (NLRB) Efficiency by Assessing Not Auto-Approved Hepatocellular Carcinoma Medical Urgency Exceptions	95
Study the Outcomes of Split Paediatrics Kidney Transplant in Adult Recipients: Single Centered Retrospective Cohort Study	94
Transplant without Borders: Expansion of International Transplant Centers	91
Predictors of Time on Dialysis Before Referral to Evaluation for Renal Transplant: A Comparison of Community Hospital and Academic Medical Center	90
Evaluating Differences in Neighborhood Resource Deprivation in Liver Transplantation: Insights from Single versus Multiple Etiologies of Liver Failure	83

Healthcare Resource Utilization, Total Healthcare Costs and Mortality in Patients with Invasive Aspergillosis and a History of Transplant	81
Access Inhibited by Intersecting Marginalization (AIIM) in Kidney Transplantation	79
In-Depth T-Cell Phenotyping and Its Association with Relapse in Transplant Recipients with Human Cytomegalovirus (CMV) DNAemia	79
Cardiovascular Risks and Cognitive Recovery After Kidney Transplant	78
LAG3 Regulates Donor Specific Antibody Responses Following Kidney Transplantation	77
Development of a Novel Mouse Model of Focal Segmental Glomerulosclerosis Recurrence Post-Kidney Transplantation Mediated by Anti-Nephrin Antibodies	73
Identifying Molecular Signatures in Donation After Circulatory Death Liver Grafts Undergoing In-Situ Normothermic Regional Perfusion	73
Anticipating Hurdles to Benefitting from Advanced Biopreservation of Human Organs	72
Impact of Ideal Body Weight-Based rATG Induction Dosing on Rejection and Infection Rates in Liver Transplant Recipients	71
Real-World Use of Letermovir and Maribavir in Solid Organ Transplant: A Dual-Centre Study	68
Evaluating the Impact of Extended Ischemia Time in Biopsied High KDPI Kidney Grafts	68
Monitoring the Response to Treatment of Kidney Allograft Rejection with Donor-Derived Cell-Free DNA	68
Cost-Effective Diagnostic Testing Models Using Four Kidney Rejection Biomarkers	67
Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2is) in Kidney Transplant Recipients	66
Donor-Derived Cell-Free DNA is Not Associated with White Blood Cell Count in Heart Transplant Recipients	66
Inter-Center Variability of Biopsy-Based Transcript Diagnostics: Comparison of Banff Lesions with Molecular Scores	66
Digital Community Engagement Among Transplant Recipients, Donors, and Care Partners: A Four-Year Analysis	65
Long-Term Risks in Obese Living Kidney Donors: A Systematic Review and Meta-Analysis	65
Discarded Yet Transplantable: A Data-Driven Analysis of Kidney Survival Outcomes	63
Safety and Outcomes of Robotic-Assisted Radical Prostatectomy for Localized Prostate Cancer in Kidney Transplant Recipients	63
Pregnancy Complications Following Solid Organ Transplant Varies by Organ Type: A Multicenter Database Analysis	62
The Role of NKG2A+ NK Cells in the Control of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disorders	62
Effect of Steroids in Cirrhotic Patients with Shock Awaiting Transplant: A Single Center Retrospective Study	62
Non-Tuberculous Mycobacterium Colonization: A Contraindication for Lung Transplantation?	61
The Longest-Living Human with a Xenograft: A Qualitative Case Study	57
Normothermic Machine Perfusion Reduces Waitlist Time in Liver Transplant: A Single Center Experience	57
T Cell Profiling Reveals Functional Immune Defects in Pediatric Transplant Recipients with Chronic Epstein-Barr Virus DNAemia	56
Association of Left Atrial Strain with Major Adverse Cardiovascular Events Following Kidney Transplantation	55
Diabetes Technology Utilization Amongst Pancreas Transplant Recipients	55
Equity in Kidney Allocation: Examining Demographics in Out-of-Sequence Kidney Acceptance	55
Immunosuppressant Level Fluctuations as a Potential Surrogate Marker of Adherence	55
Long-Term Outcomes of Pre-Existing DSA in Highly Sensitized Kidney Transplant Recipients	54
A Data-Driven Approach to Predict Waiting Times in Kidney Transplantation Using Machine Learning	53
Molecular interpretation, archetype analysis, and injury dimensions improve prognostication from kidney allograft biopsies classified according to Banff 2022	53
Age and Sex Are Critical in Driving Humoral Alloimmune Response	53
Inflammatory States Affect Composition of Pretransplant Peripheral Blood Immune Cell Compartment	52
Outcomes of High KDPI Kidneys in DCD vs. DBD Transplants: A Single-Center Analysis	52
Unsupervised Machine Learning with Dynamic Time Warping Helps Understand Longitudinal dd-cfDNA Trajectories in Kidney Transplant Patients	50
Impact of Age Difference Between Donor and Recipient in Renal Transplantation	49
Zoonotic Infections in Solid Organ Transplant Recipients at a Single Center	48
Expression of CD40 on Monocytes and Lymphocytes in Kidney Transplant Patients	48
Leveraging Heterologous Immunity to Provide Insights into Alloreactivity	47
Recipient and Donor Factors Associated with BOS/CLAD-Free Graft Survival vs. Graft Survival Alone	46
Development of HLA Genotype-Informed dPCR Assay to Monitor Donor-Derived cfDNA	46
Epigenetic and Transcriptional Dynamics in Ischemia Reperfusion Injury of Liver Allografts	46
Association of Dual Noninvasive Biomarkers with 10-Year All Cause Graft Loss in a Multicenter Prospective Cohort	46
Clinical Utility of the BioFire Pneumonia Panel in the Diagnosis and Treatment of Pneumonia Among Solid Organ Transplant Patients	45
Factors Associated with Prolonged Case Time in Deceased Organ Donation	44
Disparities in Referral for Liver Transplant Evaluation in Individuals with Hepatocellular Carcinoma: The California Liver Network	44
Outcomes of Intestinal Biopsies Which Are Indeterminate for Rejection Following Intestine Transplant	43

Quantifying HLA Expression on Heart Allografts Using Imaging Mass Cytometry	43
Daratumumab (Anti-CD38) for Treatment of Antibody-Mediated Rejection of Renal Allografts	42
Overdose Deaths Are Decreasing, but Donor Numbers Continue Increasing	41
Analytical Validation of a Serum miRNA RT-qPCR Assay for Monitoring Allograft Liver Rejection	41
Innovation in Organ Transplantation through Wireless Real-Time Temperature Monitoring	41
Donor-Derived Cell-Free DNA Levels in Pediatric Liver Transplant Recipients Undergoing For-Cause and Surveillance Biopsies	41
Elevated Kidney-Derived uEVs Signal Acute Rejection Post-Transplantation	40
An ethical analysis of conditional and partially directed live kidney donation among strangers—The Israeli experience	40
Outside Front Cover	39
Increasing Azole-resistant environmental Aspergillus fumigatus in Denmark	39
Generating strategies for a national comeback in pancreas transplantation: A Delphi survey and US conference report	39
The case for providing HLA selected red cell transfusions – are we there yet?	39
International multicenter study of ultralow graft-to-recipient weight ratio grafts in adult living donor liver transplantation	39
DCDD heart transplantation with thoraco-abdominal normothermic regional perfusion and static cold storage: The experience in Spain	38
Navigating challenges in recipient selection for end-chain kidneys	38
ILTS/LICAGE Guidelines for Cardiovascular Assessment Before Liver Transplantation	38
Kaposi sarcoma herpesvirus inflammatory cytokine syndrome—a severe complication of an overlooked donor-derived infection	38
Development of a natural language processing algorithm to extract social determinants of health from clinician notes	37
First case of rapidly fatal mpox from secondary (household) transmission in a kidney transplant recipient	37
Rethinking Lactate’s Role as a Post-Transplant Outcome Predictor During Normothermic Machine Perfusion: Science or Speculation?	37
AJT Digest for Patients: Their Own Window into Key Research	36
Impact of interleukin-6 on T cells in kidney transplant recipients	36
Short- and long-term complications after living donor ileal resection	36
Eculizumab as a therapeutic approach for severe crescentic recurrence of immunoglobulin A nephropathy after kidney transplantation	35
The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients	35
Will the flu vaccine work this year?	35
Induction of fetomaternal tolerance? Suppressing B cells!	35
Long-term outcomes after normothermic machine perfusion in liver transplantation—Experience at a single North American center	35
De novo membranous nephropathy in a pig-to-baboon kidney xenograft: A new xenograft glomerulopathy	35
OFC 23rd Winter Symposium	34
Hereditary thrombotic thrombocytopenic purpura acquired through liver transplantation: A case report	34
New metrics to measure OPO performance are here: How do we ensure organizations receive feedback and improve organ donation?	34
Dynamic impact of liver allocation policy change on donor utilization	34
The benefit to waitlist patients in a national paired kidney exchange program: Exploring characteristics of chain end living donor transplants	34
Alloantibodies after simultaneous liver-kidney transplant: A story of primary nonfunction, retransplantation, and antibody-mediated rejection	33
Effects of in vivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidates	32
Polymicrobial bacteremia in a heart transplant recipient: More than what meets the eye	32
Disparities in liver transplantation: One size may not fit all	31
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept	31
Safety and efficacy of tenofovir alafenamide in preventing hepatitis B virus recurrence after liver transplantation in patients with chronic kidney disease maintained on tenofovir disoproxil fumarate:	31
The association of place-based disadvantage and access to deceased donor heart transplantation	31
Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients	31
DCD Liver Transplantation- Contemporary US Experience with NRP and NMP	30
Pediatric cardiac xenotransplantation and stakeholder engagement	30
Corrigendum to ‘Partial Bladder Transplantation with En Bloc Kidney Transplant—The First Case Report of a ‘Bladder Patch Technique’ in a Human’ [American Journal of Transplantation 8 (2008) 1060-1063]	30
Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study	30
Pure laparoscopic donor hepatectomy: Experience of 556 cases at Seoul National University Hospital	30
One Man In His Time Plays Many Parts: Transplant Surgeons’ Approach to Evolution of Career Identity	29
Intranasal therapy of IGFBP2 ameliorates lung fibrosis	29
Controlled Hypothermic Preservation of Donor Livers with Back- to-Base Normothermic Machine Perfusion Improves Clinical Outcomes and Facilitates Donor Pool Expansion	29
Rhabdomyolysis Following Living Donor Kidney Donation - an Underreported Entity?	29
Characterizing Renal Function Predictors and Outcomes in Liver Transplant Recipients Who Have Preoperative Renal Dysfunction	29
Integrating frailty into clinical care	29
Poor Post-Transplantation Renal Function Negatively Impacts Survival of Liver Transplant Recipients Despite SLK and Safety Net Kidney Transplantation	29
Cell-free DNA method for monitoring porcine-to-human xenotransplants	29
Variability in post-transplant outcomes reported by studies examining perfusion techniques in liver transplantation: a qualitative systematic review	29
Perceived Support Among Unpaid Caregivers Along the Kidney Transplant Trajectory	28
Use of TUTIVIA in the Early Post-Transplant Period for Distinction of Rejection from Quiescence Among Kidney Transplant Recipients - A Single Center Experience	28
Increased Treg in Kidney Transplant Recipients with Erythrocytosis	28
Impact of Aortoiliac Calcifications on Kidney Transplant Survival: A Latin American Cohort Study	28
Arboviral Infection in Solid Organ Transplant Recipients in Southern Thailand: A Case Series	27
Case Study: Impact of Creatine Supplementation on Kidney Function Tests in an Active Living Kidney Donor	27
The Use of Much Older Donor Hearts in Younger Recipients (Up to 28 Years Difference): Acceptable Outcomes?	27
Barriers to Living Donation in Young Adults: Insights from Kidney and Liver Donor Evaluations	27
Post-Translational Modifications to DAMPs Generated during Ischemia-Reperfusion Injury Drives Differential Allosensitization and Outcomes in Liver Transplant Recipients	27
Relationship Between Donor-Derived Cell-Free DNA and Reflux in Post-Lung Transplant Patients	27
Management in the Era Before Biomarkers: Long-Term Outcomes and Immunosuppression Strategies Following Liver Transplantation	27
Pegcetacoplan for Posttransplant Patients with Complement 3 Glomerulopathy or Primary (Idiopathic) Immune-Complex Membranoproliferative Glomerulonephritis	27
Understanding Disparities in Progression from Living Donor Candidate Evaluation to Approval: Analysis of the US SRTR Living Donor Collective	27
Efficacy and Safety of Sodium Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide 1 Agonist in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis	27
Proteomic Analysis of Perfusate from Normothermic Machine Perfusion of Human Livers Suggests Markers Associated with Organ Recovery	27
Depletion of Senescent Cells Prevents CNI-Induced Nephrotoxicity	27
Recipient TLR9 is Required for Endogenous Donor-Reactive Memory CD8 T Cell Proliferation and Effector Function to Mediate High Risk Allograft Rejection	27
Changes in Living Kidney Donors’ Expected and Received Donation Benefits and the Influence of Donor-Related Adverse Events	26
The Real World: A Single-Center Experience Launching DCD Liver Transplant Utilization	26
Impact of Donor and Recipient Characteristics on Post-Transplant ImmuKnow and AlloMap Following Heart Transplantation	26
Timing of Biopsies during Deceased Donor Kidney Allocation	26
Real-Time Bioelectronic Monitoring of Temperature and Strain to Detect Acute Rejection in a Kidney Transplant Model	26
TRANSFORM: Transplant Readiness Achieved through Novel Solutions for Obesity Reduction and Management	26
Augmented Donor Liver-Derived NK Cell Therapy for HCC and Bacteremia Prevention Post-Liver Transplantation	25

The Use of Portal Vein Anatomic Variants in Living Donor Liver Transplant - A Single Center American Experience	25
Infectious Disease Complication in Kidney Transplant Recipients with Belatacept: Systematic Review and Meta-Analysis	25
Initial Experience in a Porcine Autotransplantation Model to Validate Normothermic Ex Vivo Kidney Perfusion	25
Why Fly When You Can Drive! - Utilizing Controlled Hypothermic Preservation to Facilitate Long Distance Ground Transportation	25
The Importance of Individual Patient Stories Amplified by Social Media on Transplant Listing and Understanding	25
Restrictive Physiology Due to Microvascular Disease After Heart Transplant: When is It Time to Consider Retransplant?	24
Rejection Outcomes in Simultaneous Liver-Kidney Transplant versus Liver Transplant Alone in Recipients with Chronic Kidney Disease	24
Outcomes in LDLT Donors and Recipients with Heterozygous α-1 Antitrypsin Mutant Donors	24
An Immortalized Renal Proximal Tubule Epithelial Cellular Model Overexpressing Organic Anion Transporters 1 & 3 for Characterizing the Cellular Uptake and Intrinsic Clearance Interactions Involvin	24
Impact of Heart OCS Perfusate on Neutrophil Behavior in a Microfluidic System under Shear Stress	24
Non-Immunologic Allograft Injury Predisposes to Acute Cellular Rejection (ACR) in the First Year After Liver Transplantation (LT) in Children	24
Diagnostic Performance of Gene Expression and dd-cfDNA in Liver-Kidney Transplant Recipients	24
Using Interviews of Lay Caregivers to Identify Modifications to a Single Website for Kidney Transplant Access	24
Indocyanine Green Fluorescence Imaging in Liver Transplantation: A Systematic Review of Its Diagnostic and Prognostic Value	24
Circulating, Cell-Free Methylated DNA Indicates Cellular Sources of Allograft Injury After Liver Transplant	23
Protocol Biopsy Results Among Kidney Transplant Recipients on Belatacept with Everolimus vs Mycophenolate Mofetil	23
Endothelial Cell Expression of TCR Ligands is Necessary for Optimal Trans-Endothelial Migration of Primed CD8 T Cells into Allografts	23
Improving Transplant Access and Equity through LatinX Transplant Clinic	23
Hepatitis B Vaccination for Liver Transplant Recipients in the United States	23
Pig Kidney Xenograft Size after Pig-to-Human Transplantation - 10 GE vs GGTA1 KO	23
Protective Effect of Taurine Against Tacrolimus-Induced Pancreatic Beta Cell Dysfunction	23
Microbial Cell-Free DNA Sequencing Diagnostics: A Critical Tool for Advancing Xenotransplantation Safety and Infection Monitoring	23
Linguistic Features of Cognitive Decline in ESKD: A Comparative Analysis of Patient Portal Messages Among Non-Transplant vs. Transplant Patients	23
Bile Duct Reconstruction in Liver Transplantation for PSC: Bile Duct Grading System and Long Term Outcomes for Roux-en-Y and Duct-to-Duct Anastomoses	23
CD8+ T Cell Immunity and Exhaustion in Asymptomatic EBV+ Pediatric Heart Transplant Patients That Carry Chronic EBV Loads	23
Temporal and Regional Trends in Adult Living Liver Donation	23
IL-13: A New Ally in the Fight for Islet Graft Survival	23
Single-Cell and Spatial Genomics Reveal T-Cell Priming, Spatially Differentiated Networks and Novel Drug Targets in Early T-Cell-Mediated Liver Transplant (TCMR, LT) Rejection	23
Donor-Derived Cell-Free DNA is Higher in Small Pediatric Transplant Recipients Receiving Kidneys from Obese Donors	23
Expanding Viability Criteria for Extended Criteria Grafts in Liver Transplantation Using Normothermic Machine Perfusion: To Transplant or to Discard?	23
Blocking NKG2A/CD94 Interaction with Qa-1-Peptide Complex Prolongs Survival of Heart Allografts	22
Tailored Steroid Protocol Use Improves Bile Drainage and Native Liver Survival After Kasai Portoenterostomy	22
Recipient γδ T Cells Contribute to Graft Rejection After Human Intestinal Transplantation	22
Prevalence of Arterial Hypertension in Kidney Transplant Recipients at the Time of One-Year Protocol Biopsy	22
APOL1 Status of HIV-Positive Kidney Transplant Recipients and Its Impact on Survival: A Single-Centre UK Experience	22
Validation of Existing Comorbidity Models and Development of a New Transplant-Specific Index	22
Heart Transplant in Cardiac Amyloidosis vs Other Restrictive Cardiomyopathies	22
Defining Optimal Cryoprotectant Agent Conditions for Cryopreservation of Regulatory T Cells for Tolerogenic Cell Therapy in Transplant Recipients	22
PHLDA1 Exacerbates Renal Ischemia-Reperfusion Injury by Suppressing Fatty Acid β-Oxidation via the PPARγ/CPT1a Pathway	22
DMSA-Based Pre-Donation Differential Renal Function Does Not Significantly Impact the New Baseline Glomerular Filtration Rate: A Retrospective Five-Year Cohort Study of 125 Kidney Donors	22
The Outcomes of Mixed Rejection by Biopsy-Based Transcriptomics	21
Profound Temporal Changes in Deceased Kidney Donors over the Last 25 Years in the United States: The Necessity of Doing More with Less Quality	21
Recovery of Living Kidney Donations by Race After the COVID-19 Pandemic	21
Patient Survival After Kidney Transplantation: Impact Frailty Evaluation with SPPB (Short Physical Peformance Battery) and Grip Strength in Patients over 65 Years	21
What is the Environmental Impact of Pediatric Liver Transplantation?	21
Post-Transplant Outcome of Acute on Chronic Liver Failure - A Single Center Comparison Study	21
Leveraging Longitudinal Donor-Derived Cell-Free DNA and Gene Expression Profiling Data for Acute Cellular Rejection Diagnosis After Heart Transplant	21
Lung Xenotransplantation Outcomes Using Multi-Gene Edited Pigs: In Vivo Transplant and Ex Vivo Human Xenoperfusion	21
Which Bela is Best? Evaluating Outcomes Among Various Belatacept Dosing Strategies in Kidney Transplant Recipients	21
Clinical Significance of Pre-Transplant Serum Albumin and Mortality in Pancreas Transplant Recipients	21
Time-Varying Risk of Post-Transplant Lymphoproliferative Disorder in Pancreas Transplant Recipients by Donor-Recipient Epstein-Barr Virus Serostatus	21
The Impact of a Transplant-Center Based Normothermic Regional Perfusion Program on Liver Transplant Volume and Finances	21
A Persistent Threat: The Burden of Pseudomonas aeruginosa Left Ventricular Assist Device Infections	20
Characterizing proximity and transfers of deceased organ donors to donor care units in the United States	20
The dangerous precedent of censoring scientific dissemination	20
“Horses for courses” computed tomography or predicted total lung capacity for size matching in lung transplantation	20
Utilizing pathophysiological concepts of ischemia-reperfusion injury to design renoprotective strategies and therapeutic interventions for normothermic ex vivo kidney perfusion	20
Association Between California Kidney Transplant Waitlist and Living Donor Kidney Transplantation	20
Novel modified iliac artery stent graft with side branch extension facilitating kidney transplant in severe aortoiliac occlusive disease	20
Unexpected incidental finding in a prospective living kidney donor	20
CDC guidance on new pentavalent meningococcal vaccine	20
Down to the coronary arteries: When spatial multiomics open up a narrow path	20
Sex disparity in liver allocation within Eurotransplant	20
Reply to letter in reference to “Kidney graft directly implanted on endovascular stent in external iliac artery: A preliminary experience”	20
Letter in reference to “Economic evaluation of weight loss and transplantation strategies for kidney transplant candidates with obesity”	20
Spatial multiomics of arterial regions from cardiac allograft vasculopathy rejected grafts reveal novel insights into the pathogenesis of chronic antibody-mediated rejection	20
10 degree C static storage of porcine donation after circulatory death livers improves biliary viability and mitigates ischemia-reperfusion injury	20
A plan to save lives: Hong Kong–mainland China second-tier mutual assistance allocation	19
SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients	19
Donor utilization in heart transplant with donation after circulatory death in the United States	19
Robotic kidney transplantation from deceased donors: A single-center experience	19
Normothermic ex situ pancreas perfusion for the preservation of porcine pancreas grafts	19
The short end of the stick: Access to lung transplantation for short-statured patients in the composite allocation score era	19
Prevention of Mollicute transmitted infections from donor lungs after lung transplant	19
Utilization and outcomes of deceased donor SARS-CoV-2–positive organs for solid organ transplantation in the United States	19
Increasing liver organ acquisition fees and the risk of a tragedy of the commons	19
Body composition and the skeletal muscle compartment in liver transplantation: Turning challenges into opportunities	19
A French multicenter randomized-controlled trial of hypothermic oxygenated perfusion in extended criteria donor liver transplantation (HOPExt)	19
Incomplete tissue product tracing during an investigation of a tissue-derived tuberculosis outbreak	19
Anatomical variations of left hepatic vein and outflow reconstruction techniques in pediatric living donor liver transplantation	19
First report of auxiliary liver transplantation for severe cholangiopathy after SARS-CoV-2 respiratory infection	18
Immunosuppressive therapy after solid organ transplantation and the gut microbiota: Bidirectional interactions with clinical consequences	18
2025 Report of the Sensitization in Transplantation: Assessment of Risk Working Group on donor-derived cell-free DNA: Establishing analytical validity as the basis for appropriate and effective clinic	18
Back-table intra-arterial administration of C1 esterase inhibitor to deceased donor kidney allografts improves posttransplant allograft function: Results of a randomized double-blind placebo-controlle	18
Regarding normothermic regional perfusion: Arguing by insistence is not a strong argument	18
The impact of machine perfusion of the heart on warm ischemia time and organ yield in donation after circulatory death	18
Specific human leucocyte antigen-DQ risk epitope mismatches are associated with chronic lung allograft dysfunction after lung transplantation	18
Sowing “seeds of trust”: How trust in normothermic regional perfusion is built in a continuum of care	18
MELD-based allocation at 20: Can we evolve and mature?	18
Donor programmed cell death 1 ligand 1 is required for organ transplant tolerance in major histocompatibility complex-mismatched mixed chimeras although programmed cell death 1 ligand 1 and major hist	18
Adjusting for race in metrics of organ procurement organization performance	18
Oxidative stress and related metabolic alterations are induced in ex situ perfusion of donated hearts regardless of the ventricular load or leukocyte depletion	18
Trained immunity: Can we get one transplanted kidney to last a lifetime?	17
Continuous donor-recipient age matching: A chance for kidney allocation in the Eurotransplant region	17
	17